CMS Open Payments · Tool
Aesculap Biologics, LLC vs Hu-Friedy Mfg. Co., LLC
Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.
A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.
Compare Different Companies
Relationship comparison
Which recorded payment profile is more concentrated?
Aesculap Biologics, LLC has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 7,394, versus 1,438 for the other company. Its single largest recorded recipient represents 85.8% of that company's General Payments recipient total.
HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.
- Aesculap Biologics, LLC
- HHI 7,394 · top recipient 85.8%
- Ranked #210 of 1,838 companies by HHI
- Hu-Friedy Mfg. Co., LLC
- HHI 1,438 · top recipient 36.1%
- Ranked #885 of 1,838 companies by HHI
Payment Overview
Aesculap Biologics, LLC
- Total Payments
- $559.6K
- % of Industry
- 0.0%
- Transactions
- 92
- Avg per Transaction
- $6.1K
- Recipients
- 11
- Avg per Recipient
- $50.9K
- Payment Types
- 2
- Top Payment Type
- Consulting Fee
Hu-Friedy Mfg. Co., LLC
- Total Payments
- $554.1K
- % of Industry
- 0.0%
- Transactions
- 2,442
- Avg per Transaction
- $226.90
- Recipients
- 2,442
- Avg per Recipient
- $226.90
- Payment Types
- 5
- Top Payment Type
- Royalty or License
Highlighted values indicate the higher figure for each metric.
Total payments compared
Aesculap Biologics, LLC vs Hu-Friedy Mfg. Co., LLC - total reported payments in CMS Open Payments PY2024
General Payment Types Breakdown
Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.
Aesculap Biologics, LLC
85.8%
14.2%
Hu-Friedy Mfg. Co., LLC
48.9%
35.7%
11.3%
2.6%
1.4%
Top 5 General-Payment Recipients
This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.
Aesculap Biologics, LLC
- 1
MICHAEL BAUER
$4,500.00 · 3 txns
- 2
BRIAN COLE
$237.14 · 2 txns
- 3
KEVIN PLANCHER
$110.19 · 1 txns
- 4
JASON DRAGOO
$82.55 · 1 txns
- 5
KENNETH ZASLAV
$82.55 · 1 txns
Hu-Friedy Mfg. Co., LLC
- 1
RONALD GOLDSTEIN
$200,281.86 · 9 txns
- 2
STEVEN BOWMAN
$36,698.46 · 5 txns
- 3
EDWARD ALLEN
$33,706.50 · 11 txns
- 4
JOEL BERG
$24,000.00 · 12 txns
- 5
ENRIQUE CRUZ
$20,578.84 · 4 txns
Summary Comparison
| Metric | Aesculap Biologics, LLC | Hu-Friedy Mfg. Co., LLC |
|---|---|---|
| Total Payments | $559.6K | $554.1K |
| % of Industry Total | 0.0% | 0.0% |
| Transaction Count | 92 | 2,442 |
| Avg per Transaction | $6.1K | $226.90 |
| Recipient Count | 11 | 2,442 |
| Avg per Recipient | $50.9K | $226.90 |
| Payment Type Count | 2 | 5 |
| Top Payment Type | Consulting Fee | Royalty or License |
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.